Zurück zu den Rankings

Walgreens Boots Alliance, Inc. (WBA)

NEGATIVE

Fundamental

~0

Kurs

$-

Marktkapitalisierung

-

Teil 1 · Was das Unternehmen wert ist

Übersicht

Keine Beschreibung verfügbar.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

No editorial profile for this company yet

No competitor list for this company yet.

Begrenzte Finanzdaten verfügbar (0 % der Kennzahlen). Scores spiegeln möglicherweise die Fundamentaldaten dieses Unternehmens nicht genau wider.

Bilanz & Liquidität

Umsatz

-

Nettogewinn

-

Freier Cashflow

-

Gesamtes Eigenkapital

-

Gesamtverbindlichkeiten

-

Current Ratio

0.68

Zinsdeckungsgrad

-

Schulden/EBITDA

-

Gewinn je Aktie

Umsatz & Nettogewinn

Freier Cashflow

Ertragsaufschlüsselung

Historische Aufstellung

Margen im Zeitverlauf

Verschuldung im Zeitverlauf

Wie schwer die Schulden wiegen

Wachstumsraster

Wachstum — Umsatz

Bewertungskennzahlen

P/E-Verhältnis

-

ROE

-72.7%

P/B-Verhältnis

-

P/FCF

-

Bruttomarge

-

ROIC

-

Rentabilitäts-Radar

Value Creation (Economic Moat)

ROIC

-

WACC

8.0%

ROIC − WACC

-

Fundamentalanalyse-Kriterien

Bestanden (0)

Nicht bestanden (0)

Nicht verfügbar (1)

  • Error fetching data

Piotroski F-Score

-/9

Ernsthafte finanzielle Bedenken

Gewinnqualität

-

Niedrige Qualität: Rechnungslegung prüfen

Aktienverwässerung

-

Aktienrückkäufe. Aktionärsfreundlich

Unternehmensführung

Teil 2 · Der Preis und der Einstiegszeitpunkt

Dieser Teil sagt nicht, ob das Unternehmen etwas taugt: Er hilft bei der Wahl des Kaufzeitpunkts, nachdem die Fundamentaldaten überzeugt haben. Enthalten: technische Analyse, Potenzial, historische Drawdowns, Gamma-Exposure.

Latest News

Recent headlines for WBA, sourced from Markets Gazette.

  • 6/9/2026NEUTRAL
    Boots Owner in Talks on Possible $10 Billion Sale, FT Says

    Walgreens Boots Alliance, the parent company of the UK health and beauty retailer Boots, is reportedly in discussions for a potential sale valued at approximately $10 billion. The Financial Times reports that potential suitors include the Weston family and Australian pharmacy group Sigma Healthcare Ltd. This news indicates a significant strategic move by WBA, potentially reshaping its portfolio. Investors will monitor the progress of these talks, as a sale could unlock value or signal a divestment of a key, albeit underperforming, asset.

  • 4/2/2026POSITIVE
    Walgreens’ Private Equity Owner Plans to Double Pharmacy Chain’s Profits

    The private equity owner of Walgreens has outlined ambitious plans to double the pharmacy chain's profitability within the coming years, following a substantial $10 billion acquisition. This strategic initiative, revealed by sources close to the deal, signals a strong conviction in Walgreens' turnaround potential. Investors will be closely watching the execution of these plans, which are expected to focus on operational efficiencies and market expansion. The news suggests a potential upside for the company's valuation, pending successful implementation of the private equity firm's growth strategy.

  • 2/23/2026NEGATIVE
    Walgreens widens job cuts amid store closures

    Walgreens Boots Alliance is escalating its restructuring efforts, announcing a new wave of job cuts and significant store closures. This action is part of a broader trend of distress within the U.S. retail pharmacy sector, highlighted by similar moves from competitors like CVS, which has laid off workers to focus on online delivery, and the bankruptcy of Rite Aid. Walgreens' strategy aims to cut costs and streamline its physical footprint to navigate a rapidly changing market and intense competitive pressure. Investors are closely watching to see if these drastic measures will be enough to reverse the negative trend and set the company back on a path to sustainable growth, amidst a landscape also marked by store closures from giants like Amazon.

via Markets Gazette